Thanks for Connecting With Us at NANS 2026

Ralph Aarsman, MD​

Evaluation of Neurophysiologic Correlates of Maximal Analgesia Using EVOKE™ Therapy : Insights from Triangle Pain Clinic

Eric Cornidez​​, MD

Evaluating EVOKE™ Therapy for Consistent Pain Relief from Trial to Post-Implant Phase: A Single-Center Analysis​

Timothy Deer​, MD​

ASPN Guidelines on Programming and Coding SCS Devices for Treatment of Chronic Intractable Pain​

Timothy Deer​, MD​

Clinical Impact of EVOKE™ Therapy with EVA™ Sensing Technology: Real-World Outcomes and Patient Empowerment​

Jan willem Kallewaard​, MD

Towards Precision Dosing in SCS: Utilizing Objective Spinal Activation Thresholds​

Marcin Karcz, MD​​

Real-World Outcomes of EVOKE™ Therapy with EVA™ Sensing Technology: Insights from the ULTRA Study​

Harold Nijhuis​, MD

Maximum Analgesic Effect using EVOKE™ Therapy : Retrospective Analysis from the Multicenter, Real-World, DR Study​

Jason Pope, MD

Consistent Therapeutic Neural Activation Requires Equivalent Prevention of Over- and Under-Stimulation: An ECAP Study Sub-Analysis ​

Jason Pope, MD

ECAP Study Insights: Trial Phase Therapeutic and Neural Responses Replicated at Post-Implant Visit with EVOKE™ Therapy ​

Jason Pope, MD

Long-term EVOKE™ Therapy Outcomes in Same Day Objective SCS Trial Responders: 12-Month Results

Lawson Smith​, MD​

Neural Dosing using EVOKE™ Therapy with EVA™ Sensing Technology Parallels Maximum Analgesia Requirements​

Derron Wilson​, MD​

Neural Panel Study: Interim Analysis of EVA Sensing Technology Platform to Deliver EVOKE™ Therapy ​